iShares NASDAQ US Biotechnology UCITS ETF (SWX:BTEC)
10.48
+0.17 (1.65%)
Last updated: Sep 22, 2026, 4:11 PM CET
SWX:BTEC Holdings Information
SWX:BTEC is an equity ETF with a total of 255 individual holdings. The top holdings are Gilead Sciences stock at 8.38%, Vertex Pharmaceuticals at 7.61%, Amgen at 7.31%, Regeneron Pharmaceuticals at 5.30%, and Moderna at 4.11%.
Total Holdings
255
Top 10 Percentage
44.03%
Asset Class
Equity
ETF Category
Sector Equity Biotechnology
Assets
444.88M
PE Ratio
n/a
Breakdown by Asset Class
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | GILD | Gilead Sciences, Inc. | 8.38% |
| 2 | VRTX | Vertex Pharmaceuticals Incorporated | 7.61% |
| 3 | AMGN | Amgen Inc. | 7.31% |
| 4 | REGN | Regeneron Pharmaceuticals, Inc. | 5.30% |
| 5 | MRNA | Moderna, Inc. | 4.11% |
| 6 | RVMD | Revolution Medicines, Inc. | 2.73% |
| 7 | ILMN | Illumina, Inc. | 2.42% |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.14% |
| 9 | BIIB | Biogen Inc. | 2.13% |
| 10 | ROIV | Roivant Sciences Ltd. | 1.92% |
| 11 | ARGX | argenx SE | 1.80% |
| 12 | INSM | Insmed Incorporated | 1.75% |
| 13 | RPRX | Royalty Pharma plc | 1.74% |
| 14 | INCY | Incyte Corporation | 1.70% |
| 15 | GH | Guardant Health, Inc. | 1.61% |
| 16 | UTHR | United Therapeutics Corporation | 1.42% |
| 17 | VTRS | Viatris Inc. | 1.30% |
| 18 | MEDP | Medpace Holdings, Inc. | 1.14% |
| 19 | JAZZ | Jazz Pharmaceuticals plc | 1.04% |
| 20 | NBIX | Neurocrine Biosciences, Inc. | 0.99% |
| 21 | ASND | Ascendis Pharma A/S | 0.97% |
| 22 | EXEL | Exelixis, Inc. | 0.97% |
| 23 | SMMT | Summit Therapeutics Inc. | 0.95% |
| 24 | TEM | Tempus AI, Inc. | 0.91% |
| 25 | BBIO | BridgeBio Pharma, Inc. | 0.89% |
As of Sep 22, 2026